"I've obviously been skeptical about a getting Humanitarian Device Exemption and, drawing on my experience with the FDA, I still don't think that Canada accepting the DurAVR into its Special Access Program will have any bearing on an FDA decision about whether ViV is an unmet condition or not. I'd love to be proven wrong but that's my opinion. "
If there is a real alternative, what is it? Obviously the Canadian authorities do not believe the current incumbents of Sapien or Evolut to be alternative even in an 84year old.
- Forums
- ASX - By Stock
- AVR
- Ann: DurAVR first successful implantation Valve-in-Valve
Ann: DurAVR first successful implantation Valve-in-Valve, page-12
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$11.93 |
Change
-0.290(2.37%) |
Mkt cap ! $252.1M |
Open | High | Low | Value | Volume |
$12.20 | $12.22 | $11.21 | $199.1K | 17.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 577 | $11.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.93 | 131 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 577 | 11.590 |
1 | 890 | 11.550 |
2 | 1080 | 11.500 |
1 | 400 | 11.360 |
1 | 500 | 11.200 |
Price($) | Vol. | No. |
---|---|---|
11.930 | 131 | 1 |
12.250 | 250 | 1 |
12.500 | 1445 | 2 |
12.750 | 3000 | 1 |
12.850 | 1000 | 1 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online